Effect of RBCs on the activation of human complement by heparin-protamine complexes.
Complement activation on red cells by heparin-protamine complexes was studied by using whole human serum. C3 bound to red cells was measured by radiolabeled monoclonal antibody to C3, and fluid-phase C5a was determined by radioimmunoassay. Heparin and protamine in clinically relevant concentrations caused the binding of C3 to red cell membranes, and the measurement of C3 binding provided a sensitive indicator of complement activation produced by these complexes. Complement activation by these reagents occurred at concentration ratios of protamine and heparin at which protamine neutralized the anticoagulant effect of heparin. Heparin-protamine complexes appeared to bind to red cells and produce complement activation by the classic pathway. C5a generation with heparin-protamine complexes in serum was greatly enhanced in the presence of red cells and increased with increasing red cell concentration. This enhancement of complement activation in the presence of red cells was also seen as measured by depletion of available C3 hemolytic complement units in the fluid phase. Thus red cells seem to play an important role in activation of complement by heparin-protamine complexes.
Shastri
K A
KA
Department of Medicine, State University of New York at Buffalo.
Phillips
M J
MJ
Raza
S
S
Logue
G L
GL
Rustagi
P K
PK
D003167:Complement Activation / Q000187:drug effects*; D003176:Complement C3 / Q000378:metabolism; D050577:Complement C3-C5 Convertases / Q000378:metabolism; D003182:Complement C5 / Q000096:biosynthesis; D015936:Complement C5a; D003171:Complement Pathway, Classical / Q000187:drug effects*; D004912:Erythrocytes / Q000502:physiology*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D011479:Protamines / Q000494:pharmacology*
D003176:Complement C3; D003182:Complement C5; D011479:Protamines; D015936:Complement C5a; D006493:Heparin; D050577:Complement C3-C5 Convertases